Nalmefene Hydrochloride Oral Tablets

Nalmefene Hydrochloride Oral Tablets

Form: Oral Tablets

Strength: 18 mg

Reference Brands: Selincro(EU)

Category: Antipsychotropic Drugs

Nalmefene Hydrochloride Tablets are approved in the EU for the reduction of alcohol consumption in adult patients with alcohol dependence, under brand names like Selincro®. They are prescription-only and regulated by the European Medicines Agency (EMA) under centralized procedures. In the USA, as of now, Nalmefene tablets are not FDA-approved for alcohol dependence, though clinical trials have been conducted. EU regulatory approval includes risk management plans and post-marketing surveillance. Manufacturing requires adherence to EU-GMP guidelines. Pharmatradz.com connects you with compliant suppliers of Nalmefene Hydrochloride tablets and other psychiatric formulations for global B2B sourcing and regulatory insight.

Get Enquiry Back to Listing
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'

The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.

Related Products

Risperidone Long-Acting Injection

Strength: 12.5 mg, 25 mg, 37.5 mg, 50 mg vials/syringes

Form: Long-Acting Injection

Reference Brands: Risperdal Consta(US &EU)

View Details Get Enquiry
Zuclopenthixol Ong-Acting Im Injection (Depot)

Strength: 200 mg/mL, 500 mg/mL

Form: Long-acting IM Injection (Depot)

Reference Brands: Clopixol Depot®(US)

View Details Get Enquiry
Zuclopenthixol Short-Acting Intramuscular Injection

Strength: 50 mg/mL

Form: Short-acting Intramuscular Injection

Reference Brands: Clopixol-Acuphase®

View Details Get Enquiry
Zuclopenthixol Tablets

Strength: 10 mg, 25 mg, 40 mg

Form: Oral Tablets

Reference Brands: Clopixol®(EU)

View Details Get Enquiry

Subscribe to Our Newsletter

Stay updated on pharma trends and marketplace opportunities.

We use cookies to ensure you get the best experience. Learn more